What is the purpose of the Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial? 
The purpose of the Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial was to evaluate the efficacy of the chimeric c7E3 antibody for reducing ischemic events and mortality in patients with unstable angina refractory to standard treatment.